
Niels A.J. Cremers
Triticum Exploitatie BV, Sleperweg 44, 6222NK Maastricht, The Netherlands; Department of Gynecology and Obstetrics, Maastricht University Medical Center, The Netherlands
Dr. Niels Cremers is the Head of Research at Triticum Exploitatie B.V. This company manufactures medical devices as s the Head of Research at Triticum Exploitatie B.V.. This company manufactures Medical Devices, including wound care products based on medical-grade honey. He collaborates with clinicians and researchers worldwide to prove honey's antimicrobial and wound-healing activities only. He has more than 15 years of experience in tissue regeneration and has been recognized by Expertscape.com as a world expert (top 0.1%) in honey research and wound healing (top 1%). Dr. Cremers has over 30 peer-reviewed PubMed-indexed publications and an h-index of 17. Moreover, he is a country-corresponding member of the Apitherapy Commission of Apimondia (the World Federation of Beekeeping Associations), representing the Netherlands. Dr. Cremers holds his master's degree in biomedical sciences with majors in Human Pathobiology and Toxicology and a PhD in Medical Sciences from the Radboud University in Nijmegen.

Linsey J.F. Peters
Triticum Exploitatie BV, Sleperweg 44, 6222NK Maastricht, The Netherlands
Linsey Peters is a research associate at Triticum Exploitatie BV in Maastricht, the Netherlands, focusing on honey in wound care. She earned her bachelor's and master's degrees in biomedical sciences from Maastricht University. Further, she moved to Germany to pursue her PhD at the Institute for Cardiovascular Prevention (IPEK) at Ludwig Maximilian University (LMU) in Munich. In 2019, she and her host lab relocated to Aachen, Germany, where she continued her work at the Institute for Molecular and Cardiovascular Research (IMCAR) at RWTH Aachen University. Here, she began a joint PhD trajectory with Maastricht University in the Experimental Vascular Pathology Group. Her PhD work centered around chronic inflammation, with a specific focus on cardiovascular disease and microRNAs. The dissertation is submitted but awaits defense.
Throughout history, honey has been used in wound care for its pro-healing and antimicrobial effects. However, its popularity decreased significantly due to the invention of antibiotics. Antimicrobial resistance has renewed interest in honey as a wound care product due to its lack of risk for resistance. Honey intended for medical purposes is carefully selected and undergoes gamma-sterilization to ensure safety and clinical efficacy. This type of honey, known as medical-grade honey, is prominent in contemporary wound care. Medical-grade honey has been shown to successfully heal chronic wounds and eradicate highly resistant bacterial strains and their biofilms.
Nonetheless, several aspects remain unclear, such as the underlying molecular mechanisms. Therefore, we invite researchers and clinicians to contribute to our Methods Collection focusing on honey in wound care.
This collection aims to showcase cutting-edge research techniques related to the use of honey in wound care. We welcome submissions that focus on elucidating the effects of honey on wound healing or examining its microbiological activities. However, the scope is not limited to these areas. We are open to general approaches in wound healing or microbiology that can be adapted for honey applications. We are interested in both in vitro and in vivo techniques, as well as clinical applications of honey.
By participating in this collection, authors will have the opportunity to contribute to the development of knowledge in this dynamic field, making significant contributions to the use of honey in wound care.